Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 51: 2401-2404, 2005; 10.1373/clinchem.2005.055517
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Góth, L.
Right arrow Articles by Bigler, W. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Góth, L.
Right arrow Articles by Bigler, W. N.
Related Collections
Right arrow General Clinical Chemistry
(Clinical Chemistry. 2005;51:2401-2404.)
© 2005 American Association for Clinical Chemistry, Inc.


Technical Briefs

Blood Catalase Activity in Gestational Diabetes Is Decreased but Not Associated with Pregnancy Complications

Laszlo Góth1,5,a, Zoltán Tóth2, Ildikó Tarnai1, Maria Bérces3, Peter Török2 and William N. Bigler4

1 Department of Clinical Biochemistry, Molecular Pathology, and Clinical Analytical Chemistry,2 Department of Obstetrics and Gynecology, and3 Neonatal Intensive Care Unit, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary;4 Center for Biomedical Laboratory Science, San Francisco State University, San Francisco, CA;5 Department of Laboratory, Municipal Hospital, Sümeg, Hungary

aaddress correspondence to this author at: Department of Clinical Biochemistry Molecular Pathology, Medical and Health Science Center, University of Debrecen, PO Box 70, Debrecen H-4012, Hungary; fax 36-52-417-631, e-mail goth@jaguar.dote.hu

The first 300 words of the full text of this article appear below.

Gestational diabetes occurs with variable severity in 3%–5% of all pregnancies and may be related to oxidative stress and impaired antioxidant defenses (1). Antioxidant enzymes include superoxide dismutase, which produces hydrogen peroxide, and catalase, which consumes hydrogen peroxide. Catalase is the main regulator of hydrogen peroxide metabolism (2), which is associated with diabetes mechanisms such as Glut 4 expression, insulin secretion, insulin signaling, protein tyrosine phosphatase regulation, and glucose transport stimulation (3). Hydrogen peroxide has novel insulin-like effects, e.g., inhibition of lipolysis and reactivation of phosphoenolpyruvate carboxy kinase (4)(5), and insulin moderates hydrogen peroxide generation (6)(7) and catalase synthesis (8). High concentrations of hydrogen peroxide may damage heme proteins, cause cell death, and together with redox active metal ions, produce highly toxic hydroxyl radicals.

High catalase activity in erythrocytes seems to provide antioxidant defense for tissues with low catalase activity, particularly pancreatic beta cells. Catalase is important in antioxidant defense against hydrogen peroxide (9)(10), but there are conflicting reports of decreases (11)(12), increases (13), and no change(14) in catalase activity in diabetes. A high incidence (14%) of diabetes mellitus observed in 63 Hungarian patients with inherited catalase deficiency (1 with type 1 and 7 with type 2 diabetes) could be associated with damage to oxidation-sensitive pancreatic beta cells by exposure to long-term increased hydrogen peroxide concentrations (15), but there have been conflicting reports from small studies of maternal and embryonic catalase in rat (16) and human(17) gestational diabetes.

We compared blood catalase activity in patients with gestational diabetes, pregnant patients without diabetes, and nonpregnant nondiabetic individuals. We examined the catalase gene mutations associated with decreased catalase . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.